Pfizer Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
- Cancellation by sponsor (496)
- ARTG (489)
- Australian Public Assessment Report (AusPAR) (66)
- Prescription medicine registration (43)
- Section 14, TGO91 consent (21)
- Prescription medicine decision summary (19)
- Designation or determination (9)
- Cancellation or suspension (7)
- Prescription medicine evaluation (1)
- 2025 (13)
- 2024 (87)
- 2023 (73)
- 2022 (61)
- 2021 (126)
- 2020 (107)
- 2019 (98)
- 2018 (97)
- 2017 (73)
- 2016 (12)
- 2015 (22)
- 2014 (23)
- 2013 (9)
- 2012 (9)
- 2011 (14)
- 2010 (29)
- 2009 (13)
- 2008 (6)
- 2007 (11)
- 2006 (8)
- 2005 (4)
- 2004 (8)
- 2003 (9)
- 2002 (12)
- 2001 (8)
- 2000 (22)
- 1999 (9)
- 1998 (12)
- 1997 (18)
- 1996 (8)
- 1995 (3)
- 1994 (33)
- 1993 (19)
- 1992 (8)
- 1991 (87)
Sponsor content
1151 result(s) found, displaying 61 to 70
-
Australian Public Assessment Report (AusPAR)Cibinqo (abrocitinib) has been approved for the treatment of moderate-to-severe atopic dermatitis in adults.
-
Australian Public Assessment Report (AusPAR)Tukysa (tucatinib) has been approved to be used in combination with trastuzumab for the treatment of adult patients with RAS wild-type HER2 positive unresectable or metastatic colorectal cancer.
-
Prescription medicine decision summaryLitfulo (ritlecitinib) has been approved for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older. Alopecia areata is an autoimmune disease that causes hair loss.
-
Prescription medicine decision summaryElrexfio (elranatamab) has been provisionally approved for the treatment of adult patients with relapsed or refractory multiple myeloma and who have not benefited from 3 prior therapies.
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd
-
Cancellation by sponsorRequested by Pfizer Australia Pty Ltd